Cell  
Attenuon Home Page
spacer

Advisory Board


Roger Cohen, M.D.

Dr. Cohen is Professor of Medicine and Director of Phase I Trials at Fox Chase Cancer Center. Previously, Dr. Cohen was Director of Clinical Trials at the University of Virginia Cancer Center and was Deputy Director of the Division of Monoclonal Antibodies at the FDA Center for Biologics Evaluation and Research. Dr. Cohen is an expert in the design, conduct, and analysis of all phases of clinical trials, and has consulted for many pharmaceutical and biotechnology companies.

 

 

   
  Home / Company / Technology / Trials / News / Contact Us / 
Copyright  © 2007 Attenuon, LLC, All Rights Reserved.  Click for Legal Notice